about
CX3CR1 is a modifying gene of survival and progression in amyotrophic lateral sclerosisNovel molecular biomarkers at the blood-brain barrier in ALSChronic administration of AMD3100 increases survival and alleviates pathology in SOD1(G93A) mice model of ALSLost highway(s): barriers to postnatal cortical neurogenesis and implications for brain repairVAChT overexpression increases acetylcholine at the synaptic cleft and accelerates aging of neuromuscular junctionsNP001 regulation of macrophage activation markers in ALS: a phase I clinical and biomarker studyDifferential regulation of glutamate transporter subtypes by pro-inflammatory cytokine TNF-α in cortical astrocytes from a rat model of amyotrophic lateral sclerosis.Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse modelHumoral factors in ALS patients during disease progression.A Multiplex Protein Panel Applied to Cerebrospinal Fluid Reveals Three New Biomarker Candidates in ALS but None in Neuropathic Pain Patients.Non-steroidal anti-inflammatory drugs and amyotrophic lateral sclerosis: results from five prospective cohort studies.Type I Vs. Type II Cytokine Levels as a Function of SOD1 G93A Mouse Amyotrophic Lateral Sclerosis Disease Progression.Role of neuroinflammation in adult neurogenesis and Alzheimer disease: therapeutic approachesA PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosisAnti-Sulfoglucuronosyl Paragloboside Antibody: A Potential Serologic Marker of Amyotrophic Lateral Sclerosis.Immune response in peripheral axons delays disease progression in SOD1(G93A) mice.Neuroimmunity dynamics and the development of therapeutic strategies for amyotrophic lateral sclerosis.Increased Expressions of Plasma Galectin-3 in Patients with Amyotrophic Lateral Sclerosis.Genomics implicates adaptive and innate immunity in Alzheimer's and Parkinson's diseases.Selection and Prioritization of Candidate Drug Targets for Amyotrophic Lateral Sclerosis Through a Meta-Analysis Approach.Can transcriptomics cut the gordian knot of amyotrophic lateral sclerosis?Immunological aspects in amyotrophic lateral sclerosis.Worming forward: amyotrophic lateral sclerosis toxicity mechanisms and genetic interactions in Caenorhabditis elegans.Transcriptional analysis reveals distinct subtypes in amyotrophic lateral sclerosis: implications for personalized therapy.Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: a meta-analysis study.Cord blood as a potential therapeutic for amyotrophic lateral sclerosis.Endothelial and Astrocytic Support by Human Bone Marrow Stem Cell Grafts into Symptomatic ALS Mice towards Blood-Spinal Cord Barrier RepairCSF concentrations of adipsin and adiponectin in patients with amyotrophic lateral sclerosis.Open label study to assess the safety of VM202 in subjects with amyotrophic lateral sclerosis.Hematopoietic stem and progenitor cells as novel prognostic biomarkers of longevity in a murine model for amyotrophic lateral sclerosis.Potential new complication in drug therapy development for amyotrophic lateral sclerosis.Effect of Disease Pathologies on Transporter Expression and Function.Extra virgin olive oil: a key functional food for prevention of immune-inflammatory diseases.Extra-motor abnormalities in amyotrophic lateral sclerosis: another layer of heterogeneity.Copy Number Variations in Amyotrophic Lateral Sclerosis: Piecing the Mosaic Tiles Together through a Systems Biology Approach.Defining peripheral nervous system dysfunction in the SOD-1G93A transgenic rat model of amyotrophic lateral sclerosis.Glial activation colocalizes with structural abnormalities in amyotrophic lateral sclerosis.UNC13A confers risk for sporadic ALS and influences survival in a Spanish cohort.Proximate Mediators of Microvascular Dysfunction at the Blood-Brain Barrier: Neuroinflammatory Pathways to NeurodegenerationMCP-1/CCR2 signaling-mediated astrocytosis is accelerated in a transgenic mouse model of SOD1-mutated familial ALS
P2860
Q21132045-CE9F69A9-3404-4B77-85A3-5E3BF908043CQ27004431-AB76887C-3ACA-4844-8EE8-C99347E2DF59Q27303112-12DA8444-5AC3-4982-B929-0C1513064D98Q28084984-A8370598-CBEA-45C1-9011-6FD3AA752497Q28390893-0D292E07-DFD4-4A0C-8D3C-89519FB0C53FQ33924917-EC4446EA-5DDE-4BC9-AE07-7A770F6EBF1EQ35170318-574B8A7C-20C3-4553-AE56-9E3757A223C1Q35588631-C71CC973-DEE9-4186-8B6D-7843F370F198Q35806256-F1FA9B2F-AD6C-4696-B9A2-2855E060B97BQ35935713-94032A6C-A167-4B03-A124-4DD82636B7BDQ36327018-B06A95CF-B2D9-4CE9-9C91-4C9B06F0CAE8Q36332951-A5333049-EC73-4FA6-8D13-877C5067CEFBQ36830938-DA792AA4-94FC-4037-B759-FCA3730E1E7FQ37222808-9FD3E478-A60F-4FE6-B4CE-56B2AE94A376Q37299274-043304D5-1E1F-4FAB-AB71-08E6BB2C3D1DQ37322227-9A0F087F-DC62-4946-9A64-548A5A2BB995Q37322677-043FA215-6F07-4F72-AF3F-2A93A73B149FQ37487611-37BCA934-B430-4819-8B96-FC2D2203E78BQ37577887-C3C013D8-8129-41E3-AF02-687A28EADF56Q37712723-CEA6EB33-7122-4815-B1FA-9812D5A068DEQ38006693-F4582E28-E153-423B-844E-76C2B4AAB22CQ38170060-2D1E4D3D-D5F4-49C4-AF3E-0DF804043E60Q38214677-B8AD17E1-0B28-4E00-B436-8B6FAD979C60Q38542939-DD4D037F-C948-4180-91A5-0C0113F4DF67Q38613326-D0624C0D-ACB6-4FA4-9046-B2206064517BQ38690849-486AF021-DB23-434B-871E-A6D09A06AF12Q38730523-19413B11-71A7-40DD-8EE0-68EE02D76C6FQ38760568-1B3319FE-354E-4CC8-816E-244D67500A6AQ38760817-60B2EAD2-94A7-48F1-B52D-FC39377D1025Q38816820-02E5F826-26F4-42A5-86E0-AF3D83A16DD2Q38881707-685EEA53-4CCA-47C7-9E46-75C9CF3DAE3DQ38888360-D8D2A68F-5ADA-46A6-8927-CF1D63056007Q38991227-ECC165C8-7420-42DD-BC15-AAE3C7F2C8C9Q39041271-BE657A87-2152-4D49-87E7-360E2F0147E1Q39102149-178DDA54-79B5-4EB1-8BE4-8DCEFE3383AFQ39177294-CFECAC3B-0534-4A61-AFD6-75EF6C3D0201Q40556132-715684D9-C346-437F-91E7-C1C2ACE13B4FQ41596665-F39F6C0A-D65C-4D57-813B-B0E4C813CACFQ41613567-BC36A667-0918-4CEA-AE7E-A19DC872CE91Q41874688-2BC03FB8-195C-4B2F-B8C5-291E6EC3333F
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The Role of immune and inflammatory mechanisms in ALS.
@ast
The Role of immune and inflammatory mechanisms in ALS.
@en
type
label
The Role of immune and inflammatory mechanisms in ALS.
@ast
The Role of immune and inflammatory mechanisms in ALS.
@en
prefLabel
The Role of immune and inflammatory mechanisms in ALS.
@ast
The Role of immune and inflammatory mechanisms in ALS.
@en
P2860
P1476
The Role of immune and inflammatory mechanisms in ALS.
@en
P2093
P A McCombe
R D Henderson
P2860
P304
P356
10.2174/156652411795243450
P5008
P577
2011-04-01T00:00:00Z